Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin nasal spray plus parent-delivered Early Start Denver Model for young children with autism spectrum disorder
ACTRN12618001029280Phase 2Recruiting
- Sponsor
- University of Sydney
- Start
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in Autism Spectrum Disorder (ASD), sponsored by University of Sydney. Started Dec 2018; status: recruiting.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12618001029280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001029280.